Four U.S. senators told the Commissioner of the Food and Drug Administration they disagree with the agency’s decision to approve a pure version of the painkiller hydrocodone, Newsday reports.
Category results for "Government"
Last June, I testified before a Reference Committee at the annual meeting of the American Medical Association, explaining a resolution that American Society of Addiction Medicine had brought forward to encourage the Food and Drug Administration to reschedule hydrocodone combination products from Schedule III to Schedule II. I expected there to be few others testifying. I wasn’t at all ready for the long line of individuals standing at the “con” microphone, ready to speak against the resolution, says Dr. Stuart Gitlow, ASAM President.
The government shutdown in late September and early October likely delayed the Food and Drug Administration’s ruling on e-cigarette regulation, according to Consumer Reports.
People who are trying to fight the abuse of synthetic drugs need a centralized, national source that collects information about the latest substances, analyzes it and quickly disseminates early alerts, according to a group of experts trying to stay one step ahead of these ever-changing products.
The newly approved pure hydrocodone product, Zohydro ER (extended release), will be made by the same company that manufactures Vivitrol, a drug used to treat patients addicted to opioids or alcohol, The New York Times reports.
The Drug Enforcement Administration has made three synthetic drugs, known as NBOMe compounds, illegal for the next two years. The compounds, also known as “N-Bomb,” have been responsible for the deaths of at least 19 people in the United States in the past year.
Addiction and mental health treatment experts say they are hopeful new rules issued by the federal government that require parity between treatment for mental and physical illness will greatly expand access to care. They say a critical component of the rules’ success will be the criteria insurers use to include patients for addiction and mental health coverage.
The maker of the dietary supplement OxyElite Pro is recalling some of its products, which have been linked to an outbreak of liver illnesses, the Food and Drug Administration said Saturday.
Rules that will require health insurers to provide coverage for addiction and mental health that is equal to benefits for general medical coverage will be issued Friday by the Obama administration, The New York Times reports.
Americans turned in 647,211 pounds, or 324 tons, of expired and unwanted medications for safe and proper disposal during the most recent National Prescription Drug Take-Back Day on October 26. The event was led by the Drug Enforcement Administration.